ロード中...
How to select the optimal treatment for first line metastatic colorectal cancer
Choice of first line treatment for patients with metastatic colorectal cancer (mCRC) is based on tumour and patient related factors and molecular information for determination of individual treatment aim and thus treatment intensity. Recent advances (e.g., extended RAS testing) enable tailored patie...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Co., Limited
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3921543/ https://ncbi.nlm.nih.gov/pubmed/24574764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i4.899 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|